©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 14, 2014; 20(30): 10223-10237
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10223
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10223
Table 2 Outcome of patients with hepatocellular carcinoma treated by resection, liver transplantation, and living donor liver transplantation
| Treatment | No. of patients | 1 yr survival | 5 yr survival |
| Surgical resection | |||
| Fong et al[5] 1999 | 154 | 81% | 37% |
| Llovet et al[4] 1999 | 771 | 85% | 51% |
| Poon et al[46] 2002 | 1352 | 90% | 70% |
| Wayne et al[47] 2002 | 249 ( ≤ 5 cm) | 83% | 41% |
| Shrager et al[48] 2012 | 2061 | 60% | 46% |
| Roayaie et al[17] 2013 | 132 ( ≤ 2 cm) | - | 70% |
| Liver transplantation | |||
| Mazzaferro et al[18] 1996 | 48 | 84% | 74% |
| Bismuth et al[82] 1999 | 45 | 82% | 74% |
| Llovet et al[4] 1999 | 79 | 86% | 75% |
| Jonas et al[83] 2001 | 120 | 90% | 71% |
| Yao et al[19] 2001 | 64 | 87% | 73% |
| Living donor transplantation | |||
| Gondolesi et al[84] 2004 | 15 | - | 86% (3 yr) |
| Todo et al[85] 2004 | 137 | - | 79% (3 yr) |
- Citation: Tabrizian P, Roayaie S, Schwartz ME. Current management of hepatocellular carcinoma. World J Gastroenterol 2014; 20(30): 10223-10237
- URL: https://www.wjgnet.com/1007-9327/full/v20/i30/10223.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i30.10223